<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="editorial">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Nutr.</journal-id>
<journal-title>Frontiers in Nutrition</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Nutr.</abbrev-journal-title>
<issn pub-type="epub">2296-861X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fnut.2024.1395491</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Nutrition</subject>
<subj-group>
<subject>Editorial</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: Role of nutrition in skeletal muscle atrophy and sarcopenia</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Tong</surname> <given-names>Tao</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1241161/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Quan</surname> <given-names>Helong</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/494922/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Kim</surname> <given-names>Chang Keun</given-names></name>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1988487/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Zeng</surname> <given-names>Weicai</given-names></name>
<xref ref-type="aff" rid="aff6"><sup>6</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1988159/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Key Laboratory of Precision Nutrition and Food Quality, Key Laboratory of Functional Dairy, Ministry of Education, College of Food Science and Nutritional Engineering, China Agricultural University</institution>, <addr-line>Beijing</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Key Laboratory of Safety Assessment of Genetically Modified Organism (Food Safety), Ministry of Agriculture</institution>, <addr-line>Beijing</addr-line>, <country>China</country></aff>
<aff id="aff3"><sup>3</sup><institution>Beijing Laboratory for Food Quality and Safety</institution>, <addr-line>Beijing</addr-line>, <country>China</country></aff>
<aff id="aff4"><sup>4</sup><institution>School of Sports Science and Physical Education, Research Center of Sports and Health Science, Northeast Normal University</institution>, <addr-line>Changchun</addr-line>, <country>China</country></aff>
<aff id="aff5"><sup>5</sup><institution>Department of Human Physiology, Korea National Sport University</institution>, <addr-line>Seoul</addr-line>, <country>Republic of Korea</country></aff>
<aff id="aff6"><sup>6</sup><institution>Antioxidant Polyphenols Team, Department of Food Engineering, Sichuan University</institution>, <addr-line>Chengdu</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited and reviewed by: Ellen E. Blaak, Maastricht University, Netherlands</p></fn>
<corresp id="c001">&#x0002A;Correspondence: Weicai Zeng <email>weicaizeng&#x00040;qq.com</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>03</day>
<month>05</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>11</volume>
<elocation-id>1395491</elocation-id>
<history>
<date date-type="received">
<day>04</day>
<month>03</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>04</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2024 Tong, Quan, Kim and Zeng.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Tong, Quan, Kim and Zeng</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<related-article id="RA1" related-article-type="commentary-article" xlink:href="https://www.frontiersin.org/research-topics/48038/role-of-nutrition-in-skeletal-muscle-atrophy-and-sarcopenia/magazine" ext-link-type="uri">Editorial on the Research Topic <article-title>Role of nutrition in skeletal muscle atrophy and sarcopenia</article-title></related-article>
<kwd-group>
<kwd>skeletal muscle atrophy</kwd>
<kwd>sarcopenia</kwd>
<kwd>protein synthesis/proteolysis</kwd>
<kwd>nutrition</kwd>
<kwd>dietary intervention</kwd>
</kwd-group>
<counts>
<fig-count count="0"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="9"/>
<page-count count="2"/>
<word-count count="1450"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Nutrition and Metabolism</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>Approximately 40%&#x02013;50% of the body mass consists of skeletal muscle, which is important for human energy metabolism. Its quality and functional integrity are crucial to maintaining the normal function and metabolic homeostasis of the musculoskeletal system (<xref ref-type="bibr" rid="B1">1</xref>). Muscle atrophy reduces strength and endurance, which restricts activity, decreases the quality of life, increases the risk of falls and fractures, and starts a vicious cycle of muscle disuse that exacerbates muscle weakness and loss. The atrophy of skeletal muscle has various causes, including aging, cancer, metabolic diseases, sepsis, bed rest, and denervation (<xref ref-type="bibr" rid="B2">2</xref>). Sarcopenia, known as the most prevalent type of skeletal muscle atrophy in humans, is primarily associated with aging. Notably, as the aging of the global population continues to deepen, sarcopenia has become a serious public health problem, causing huge direct or indirect socioeconomic burdens (<xref ref-type="bibr" rid="B3">3</xref>). Limited success has been achieved in clinical trials testing therapeutics against skeletal muscle atrophy and sarcopenia (<xref ref-type="bibr" rid="B4">4</xref>). Therefore, finding dietary approaches for the prevention and treatment of muscle atrophy and sarcopenia has been a research hotspot in the fields of nutrition, medicine, and biology.</p>
<p>Highly dynamic, skeletal muscle reacts to a variety of stimuli, particularly mechanical load variations. The main cause of muscle atrophy in healthy individuals is muscular disuse, which also impacts protein expression, metabolism, skeletal muscle phenotype, and morphological features (<xref ref-type="bibr" rid="B5">5</xref>). Decreased physical activity is mostly due to reduced ambulatory activity, lockdowns imposed, illnesses necessitating bed rest, or discomfort or impairments from chronic conditions. Spinal cord injury is a severe, incapacitating condition that causes skeletal muscle innervation loss, lower motor function, and considerably reduced skeletal muscle load, leading to atrophy (<xref ref-type="bibr" rid="B6">6</xref>). <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnut.2023.1099143">Xu et al.</ext-link> indicated that oxidative stress injury and inflammation represented the primary mechanisms of skeletal muscle atrophy following spinal cord injury. This included various pathways, including the autophagic lysosome system, the ubiquitin-proteasome system, the IGF-1/PI3K/Akt/mTOR signaling pathway, and the hypothalamus-growth hormone-IGF-1 axis (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnut.2023.1099143">Xu et al.</ext-link>).</p>
<p>Inflammation is essential to the pathology of illnesses linked to dysfunctional skeletal muscles (<xref ref-type="bibr" rid="B7">7</xref>). A number of illnesses, such as chronic obstructive pulmonary disorder (COPD) and asthma, are marked by persistent inflammation or an increase in inflammatory mediators. Even though the pathologies of these disease states vary, they are all characterized by skeletal muscle mass loss and physiological disruption. Pro-inflammatory cytokines play a major role in the chronic inflammation that characterizes several of these diseases (<xref ref-type="bibr" rid="B8">8</xref>). The data from 3,389 participants in the National Health and Nutrition Examination Survey (NHANES) from 1999 to 2006 and 2011 to 2018 showed a significant positive association between the risk of sarcopenia in asthmatic patients and their dietary inflammatory index levels, as reported by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnut.2023.1215688">Lin et al.</ext-link> Therefore, decreasing the intake of these pro-inflammatory elements may help prevent sarcopenia. To understand the function of nutrition in patients with coexisting COPD and sarcopenia, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnut.2023.1214684">Nan et al.</ext-link> summarized the intrinsic mechanisms of both conditions.</p>
<p>Diet is an important determinant of skeletal muscle atrophy. Muscle atrophy can be caused by a variety of dietary variables, including insufficient protein consumption, vitamin D deficiency, and a diet low in antioxidants and long-chain polyunsaturated fatty acids (<xref ref-type="bibr" rid="B9">9</xref>). After screening data selected from the 2011&#x02013;2014 NHANES, including 6,019 American adults, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnut.2023.1147869">Wu et al.</ext-link> showed that the composite dietary antioxidant index and the dietary antioxidants zinc, vitamin E, and selenium were significantly correlated with handgrip strength in males, while only zinc was related to handgrip strength among dietary antioxidants in females. Additionally, eating a diverse range of foods can lower the risk of unfavorable health outcomes like physical dysfunction and death. Dietary diversity score refers to the number of various foods or food groups within a specific timeframe, where higher scores signify a broader range of foods consumed. Using the data from 6,624 older Chinese adults, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnut.2023.1218453">Du et al.</ext-link> showed that sarcopenia risk was lower in those with higher dietary diversity scores for the total diet, animal-based diet, and plant-based diet. Therefore, consuming a diverse range of foods is crucial for maintaining bodily function (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnut.2023.1218453">Du et al.</ext-link>).</p>
<p>In summary, this Research Topic provides the most recent information on the impact of diets or dietary components on skeletal muscle atrophy and sarcopenia while updating the molecular mechanisms that mediate and orchestrate muscle mass loss in disease. It offers new insights into the possible strategies for the management and prevention of these conditions. Meanwhile, due to the complex pathogenesis of skeletal muscle atrophy and existing inter-individual variability, precise nutrition for individuals with skeletal muscle atrophy will be a future research trend.</p>
<sec sec-type="author-contributions" id="s1">
<title>Author contributions</title>
<p>TT: Writing &#x02013; original draft, Writing &#x02013; review &#x00026; editing. HQ: Writing &#x02013; original draft, Writing &#x02013; review &#x00026; editing. CK: Writing &#x02013; original draft, Writing &#x02013; review &#x00026; editing. WZ: Writing &#x02013; original draft, Writing &#x02013; review &#x00026; editing.</p>
</sec>
</body>
<back>
<sec sec-type="funding-information" id="s2">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was supported by Beijing Natural Science Foundation (grant number 7222249).</p>
</sec>
<sec sec-type="COI-statement" id="conf1">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s3">
<title>Publisher&#x00027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>Y</given-names></name> <name><surname>Liu</surname> <given-names>Q</given-names></name> <name><surname>Quan</surname> <given-names>H</given-names></name> <name><surname>Kang</surname> <given-names>SG</given-names></name> <name><surname>Huang</surname> <given-names>K</given-names></name> <name><surname>Tong</surname> <given-names>T</given-names></name></person-group>. <article-title>Nutraceuticals in the prevention and treatment of the muscle atrophy</article-title>. <source>Nutrients</source>. (<year>2021</year>) <volume>13</volume>:<fpage>1914</fpage>. <pub-id pub-id-type="doi">10.3390/nu13061914</pub-id><pub-id pub-id-type="pmid">34199575</pub-id></citation></ref>
<ref id="B2">
<label>2.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sartori</surname> <given-names>R</given-names></name> <name><surname>Romanello</surname> <given-names>V</given-names></name> <name><surname>Sandri</surname> <given-names>M</given-names></name></person-group>. <article-title>Mechanisms of muscle atrophy and hypertrophy: implications in health and disease</article-title>. <source>Nat Commun.</source> (<year>2021</year>) <volume>12</volume>:<fpage>330</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-020-20123-1</pub-id><pub-id pub-id-type="pmid">33436614</pub-id></citation></ref>
<ref id="B3">
<label>3.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname> <given-names>S</given-names></name> <name><surname>Larsson</surname> <given-names>SC</given-names></name></person-group>. <article-title>Epidemiology of sarcopenia: prevalence, risk factors, and consequences</article-title>. <source>Metabolism.</source> (<year>2023</year>) <volume>144</volume>:<fpage>155533</fpage>. <pub-id pub-id-type="doi">10.1016/j.metabol.2023.155533</pub-id><pub-id pub-id-type="pmid">36907247</pub-id></citation></ref>
<ref id="B4">
<label>4.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Domaniku</surname> <given-names>A</given-names></name> <name><surname>Bilgic</surname> <given-names>SN</given-names></name> <name><surname>Kir</surname> <given-names>S</given-names></name></person-group>. <article-title>Muscle wasting: emerging pathways and potential drug targets</article-title>. <source>Trends Pharmacol Sci.</source> (<year>2023</year>) <volume>44</volume>:<fpage>705</fpage>&#x02013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1016/j.tips.2023.07.006</pub-id><pub-id pub-id-type="pmid">37596181</pub-id></citation></ref>
<ref id="B5">
<label>5.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nunes</surname> <given-names>EA</given-names></name> <name><surname>Stokes</surname> <given-names>T</given-names></name> <name><surname>McKendry</surname> <given-names>J</given-names></name> <name><surname>Currier</surname> <given-names>BS</given-names></name> <name><surname>Phillips</surname> <given-names>SM</given-names></name></person-group>. <article-title>Disuse-induced skeletal muscle atrophy in disease and nondisease states in humans: mechanisms, prevention, and recovery strategies</article-title>. <source>Am J Physiol Cell Physiol.</source> (<year>2022</year>) <volume>322</volume>:<fpage>C1068</fpage>&#x02013;<lpage>C84</lpage>. <pub-id pub-id-type="doi">10.1152/ajpcell.00425.2021</pub-id><pub-id pub-id-type="pmid">35476500</pub-id></citation></ref>
<ref id="B6">
<label>6.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Otzel</surname> <given-names>DM</given-names></name> <name><surname>Kok</surname> <given-names>HJ</given-names></name> <name><surname>Graham</surname> <given-names>ZA</given-names></name> <name><surname>Barton</surname> <given-names>ER</given-names></name> <name><surname>Yarrow</surname> <given-names>JF</given-names></name></person-group>. <article-title>Pharmacologic approaches to prevent skeletal muscle atrophy after spinal cord injury</article-title>. <source>Curr Opin Pharmacol.</source> (<year>2021</year>) <volume>60</volume>:<fpage>193</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.coph.2021.07.023</pub-id><pub-id pub-id-type="pmid">34461564</pub-id></citation></ref>
<ref id="B7">
<label>7.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname> <given-names>Y</given-names></name> <name><surname>Li</surname> <given-names>M</given-names></name> <name><surname>Chang</surname> <given-names>M</given-names></name> <name><surname>Liu</surname> <given-names>R</given-names></name> <name><surname>Qiu</surname> <given-names>J</given-names></name> <name><surname>Wang</surname> <given-names>K</given-names></name> <etal/></person-group>. <article-title>Inflammation: Roles in skeletal muscle atrophy</article-title>. <source>Antioxidants-Basel.</source> (<year>2022</year>) <volume>11</volume>:<fpage>1686</fpage>. <pub-id pub-id-type="doi">10.3390/antiox11091686</pub-id><pub-id pub-id-type="pmid">36139760</pub-id></citation></ref>
<ref id="B8">
<label>8.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Londhe</surname> <given-names>P</given-names></name> <name><surname>Guttridge</surname> <given-names>DC</given-names></name></person-group>. <article-title>Inflammation induced loss of skeletal muscle</article-title>. <source>Bone.</source> (<year>2015</year>) <volume>80</volume>:<fpage>131</fpage>&#x02013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1016/j.bone.2015.03.015</pub-id><pub-id pub-id-type="pmid">26453502</pub-id></citation></ref>
<ref id="B9">
<label>9.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kiuchi</surname> <given-names>Y</given-names></name> <name><surname>Doi</surname> <given-names>T</given-names></name> <name><surname>Tsutsumimoto</surname> <given-names>K</given-names></name> <name><surname>Nakakubo</surname> <given-names>S</given-names></name> <name><surname>Kurita</surname> <given-names>S</given-names></name> <name><surname>Nishimoto</surname> <given-names>K</given-names></name> <etal/></person-group>. <article-title>Association between dietary diversity and sarcopenia in community-dwelling older adults</article-title>. <source>Nutrition.</source> (<year>2023</year>) <volume>106</volume>:<fpage>111896</fpage>. <pub-id pub-id-type="doi">10.1016/j.nut.2022.111896</pub-id><pub-id pub-id-type="pmid">36470116</pub-id></citation></ref>
</ref-list>
</back>
</article>